CA3165298A1 - Efficient process for making 6-carboxy benzoxazole derivatives - Google Patents
Efficient process for making 6-carboxy benzoxazole derivativesInfo
- Publication number
- CA3165298A1 CA3165298A1 CA3165298A CA3165298A CA3165298A1 CA 3165298 A1 CA3165298 A1 CA 3165298A1 CA 3165298 A CA3165298 A CA 3165298A CA 3165298 A CA3165298 A CA 3165298A CA 3165298 A1 CA3165298 A1 CA 3165298A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- dichlorophenyl
- acid
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/18—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951691P | 2019-12-20 | 2019-12-20 | |
| US62/951,691 | 2019-12-20 | ||
| US202063120426P | 2020-12-02 | 2020-12-02 | |
| US63/120,426 | 2020-12-02 | ||
| PCT/IB2020/062040 WO2021124158A1 (en) | 2019-12-20 | 2020-12-16 | Efficient process for making 6-carboxy benzoxazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3165298A1 true CA3165298A1 (en) | 2021-06-24 |
Family
ID=73856234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3165298A Pending CA3165298A1 (en) | 2019-12-20 | 2020-12-16 | Efficient process for making 6-carboxy benzoxazole derivatives |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12410145B2 (https=) |
| EP (1) | EP4077287B1 (https=) |
| JP (1) | JP2023507399A (https=) |
| KR (1) | KR20220114626A (https=) |
| CN (1) | CN115135639B (https=) |
| AU (1) | AU2020406455B2 (https=) |
| BR (1) | BR112022012097A2 (https=) |
| CA (1) | CA3165298A1 (https=) |
| ES (1) | ES3055912T3 (https=) |
| HR (1) | HRP20251570T1 (https=) |
| IL (1) | IL294115A (https=) |
| MX (1) | MX2022007787A (https=) |
| TW (1) | TWI771827B (https=) |
| WO (1) | WO2021124158A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4077287B1 (en) | 2019-12-20 | 2025-11-19 | Pfizer Ireland Pharmaceuticals Unlimited Company | Efficient process for making 6-carboxy benzoxazole derivatives |
| KR102657823B1 (ko) * | 2022-03-10 | 2024-04-16 | 고려대학교 산학협력단 | 타파미디스의 신규 합성법 |
| US11970468B1 (en) | 2023-10-23 | 2024-04-30 | King Faisal University | 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5222642A (en) | 1975-08-14 | 1977-02-21 | Kawasaki Heavy Ind Ltd | Power generation device by hot water |
| GB8703975D0 (en) | 1987-02-20 | 1987-03-25 | Wellcome Found | Pesticidal compounds |
| GB8809316D0 (en) * | 1987-05-11 | 1988-05-25 | Ici America Inc | Heterocyclic ketones |
| CA2800237C (en) * | 2002-12-19 | 2016-05-17 | The Scripps Research Institute | Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| JP5419545B2 (ja) | 2009-05-25 | 2014-02-19 | 株式会社トクヤマ | オルトエステル化合物の製造方法 |
| US8168683B2 (en) | 2009-10-15 | 2012-05-01 | E. I. Du Pont De Nemours And Company | Fluorinated vinylidene cationic surfactant |
| TWI550071B (zh) * | 2011-03-25 | 2016-09-21 | 捷恩智股份有限公司 | 原酸酯化合物、液晶組成物及液晶顯示元件 |
| RU2586330C2 (ru) * | 2011-09-16 | 2016-06-10 | Пфайзер Инк. | Твердые формы ингибитора диссоциации транстиретина |
| US9499527B2 (en) * | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
| PT4349406T (pt) * | 2014-09-08 | 2026-02-04 | Pfizer | Formas sólidas cristalinas de 6-carboxi-2-(3,5-diclorofenil)-benzoxazol para utilização como medicamento |
| CN107344927A (zh) * | 2016-05-05 | 2017-11-14 | 苏州晶云药物科技有限公司 | Tafamidis葡甲胺盐的晶型E及其制备方法和用途 |
| US10766893B2 (en) * | 2017-12-20 | 2020-09-08 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
| EP4077287B1 (en) | 2019-12-20 | 2025-11-19 | Pfizer Ireland Pharmaceuticals Unlimited Company | Efficient process for making 6-carboxy benzoxazole derivatives |
-
2020
- 2020-12-16 EP EP20828342.4A patent/EP4077287B1/en active Active
- 2020-12-16 WO PCT/IB2020/062040 patent/WO2021124158A1/en not_active Ceased
- 2020-12-16 CA CA3165298A patent/CA3165298A1/en active Pending
- 2020-12-16 TW TW109144467A patent/TWI771827B/zh active
- 2020-12-16 CN CN202080096991.1A patent/CN115135639B/zh active Active
- 2020-12-16 JP JP2022537301A patent/JP2023507399A/ja active Pending
- 2020-12-16 BR BR112022012097A patent/BR112022012097A2/pt not_active Application Discontinuation
- 2020-12-16 MX MX2022007787A patent/MX2022007787A/es unknown
- 2020-12-16 HR HRP20251570TT patent/HRP20251570T1/hr unknown
- 2020-12-16 KR KR1020227024529A patent/KR20220114626A/ko not_active Withdrawn
- 2020-12-16 US US17/757,740 patent/US12410145B2/en active Active
- 2020-12-16 ES ES20828342T patent/ES3055912T3/es active Active
- 2020-12-16 IL IL294115A patent/IL294115A/en unknown
- 2020-12-16 AU AU2020406455A patent/AU2020406455B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES3055912T3 (en) | 2026-02-16 |
| AU2020406455B2 (en) | 2024-02-15 |
| TW202136222A (zh) | 2021-10-01 |
| EP4077287A1 (en) | 2022-10-26 |
| BR112022012097A2 (pt) | 2022-08-30 |
| JP2023507399A (ja) | 2023-02-22 |
| CN115135639A (zh) | 2022-09-30 |
| US20230090609A1 (en) | 2023-03-23 |
| EP4077287C0 (en) | 2025-11-19 |
| HRP20251570T1 (hr) | 2026-01-30 |
| WO2021124158A1 (en) | 2021-06-24 |
| EP4077287B1 (en) | 2025-11-19 |
| MX2022007787A (es) | 2022-07-19 |
| US12410145B2 (en) | 2025-09-09 |
| KR20220114626A (ko) | 2022-08-17 |
| TWI771827B (zh) | 2022-07-21 |
| IL294115A (en) | 2022-08-01 |
| CN115135639B (zh) | 2025-04-01 |
| AU2020406455A1 (en) | 2022-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7287978B2 (ja) | 二つの４－｛［（２ｓ）－２－｛４－［５－クロロ－２－（１ｈ－１，２，３－トリアゾール－１－イル）フェニル］－５－メトキシ－２－オキソピリジン－１（２ｈ）－イル｝ブタノイル］アミノ｝－２－フルオロベンズアミド誘導体の調製方法 | |
| US12410145B2 (en) | Efficient process for making 6-carboxy benzoxazole derivatives | |
| CA2855351A1 (en) | Novel pyrrole derivatives | |
| AU2019410521B2 (en) | Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid | |
| US7960582B2 (en) | Process for the preparation and resolution of mandelic acid derivatives | |
| KR20080020613A (ko) | (치환된) (ｒ)- 또는 (ｓ)-만델산의 동적 분할 방법 | |
| RU2810493C1 (ru) | Эффективный процесс получения производных 6-карбоксибензоксазола | |
| NO166712B (no) | Fremgangsmaate ved fremstilling av pyrrolidonderivater. | |
| WO2005007608A2 (en) | Process for the preparation and purification of 2-(alkoxyalkylidene)-3-ketoalkanoic acid esters from 3-ketoalkanoic acid esters | |
| HK40075510A (en) | Efficient process for making 6-carboxy benzoxazole derivatives | |
| US20040138232A1 (en) | Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity | |
| KR101124180B1 (ko) | （２ｓ, ３ｓ）-3-〔〔（１ｓ）-１-이소부톡시메틸-３-메틸부틸〕카르바모일〕옥시란-２-카르복실산의 염 | |
| KR102060318B1 (ko) | 신규의 중간체, 이의 제조방법, 및 이를 이용한 로수바스타틴 칼슘염의 제조방법 | |
| RU2804663C2 (ru) | Способ получения двух 4-{ [(2s)-2-{ 4-[5-хлор-2-(1h-1,2,3-триазол-1-ил)фенил]-5-метокси-2-оксопиридин-1(2h)-ил} бутаноил]амино} -2-фторбензамидных производных | |
| KR840001052B1 (ko) | 5-할로피리미딘의 제조방법 | |
| JPH0710822A (ja) | アミノ酸エステルの光学異性体分離法 | |
| JPH0641066A (ja) | ピロール誘導体の製造方法 | |
| JP2021181407A (ja) | アミドアルコール化合物の水和物及びその製造方法、並びに、及びラクトン化合物の製造方法 | |
| JPS58164573A (ja) | １−（４−クロロベンゾイル）−５−メトキシ−２−メチル−３−インド−ルアセトキシ酢酸類の製法 | |
| JP2002363171A (ja) | ４−置換−３−アミノイソオキサゾール誘導体の製法 | |
| HU179944B (hu) | Javított eljárás 2-/di- és triszubsztituált-fenil/-glicinek előállítására | |
| JPH0414114B2 (https=) | ||
| HU211665A9 (hu) | Az átmeneti oltalom az 1-19. igénypontokra vonatkozik. | |
| CA2439208A1 (en) | Process for producing optically active n-aryl-1-amino-2-propanol derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220617 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20241028 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260128 |